Sino Biopharmaceutical (1177.HK) - EPS (earnings per share)

EPS in 2021 (TTM): S$0.04839

According to Sino Biopharmaceutical's latest financial reports the company's current EPS (TTM) is S$0.04576. In 2024 the company made an earnings per share (EPS) of S$0.03357 an increase over its 2023 EPS that were of S$0.02281.

EPS history for Sino Biopharmaceutical from 1999 to 2021

Annual EPS

Year	EPS	Change
2024	S$0.03357	47.17%
2023	S$0.02281	-9.68%
2022	S$0.02526	-83.86%
2021	S$0.16	440.46%
2020	S$0.02895	7.54%
2019	S$0.02692	-70.37%
2018	S$0.09084	254.37%
2017	S$0.02563	41.55%
2016	S$0.01811	2.59%
2015	S$0.01765	17.63%
2014	S$0.01501	45.97%
2013	S$0.01028	16.34%
2012	S$0.008837	93.4%
2011	S$0.004569	-20.02%
2010	S$0.005713	33.16%
2009	S$0.004290	774.72%
2008	S$0.0004905	-79.69%
2007	S$0.002415	58.8%
2006	S$0.001521	-91.05%
2005	S$0.01699	723.97%
2004	S$0.002062	105.48%
2003	S$0.001003	-67.27%
2002	S$0.003066	-8.26%
2001	S$0.003341	17.18%
2000	S$0.002852	-3.43%
1999	S$0.002953

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Sino Biopharmaceutical (1177.HK)